Incident left bundle branch block predicts cardiovascular events and death in hypertensive patients with left ventricular hypertrophy. The LIFE Study

Aim: Whether incident left bundle branch block (LBBB) is associated with increased cardiovascular (CV) morbidity and mortality in treated hypertensive patients with left ventricular hypertrophy (LVH) is unknown. Thus, the present study aimed to examine CV outcomes of incident LBBB in treated hypertensive patients with LVH. Methods: In the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, 9,193 hypertensive patients with LVH on screening electrocardiogram (ECG) were randomized to losartan or atenolol based treatment. Participants (n = 8,567) did not have LBBB (Minnesota code 7.1) on baseline ECG. Cox regression models controlling for significant covariates assessed independent associations of incident LBBB with CV events and all-cause mortality during 4.8 years mean follow-up. Results: Annual follow-up ECGs identified 295 patients (3.4%) with incident LBBB associated with male gender (P < 0.05), older age, higher Cornell voltage (both P < 0.005) and history of diabetes, isolated systolic hypertension and prevalent CV disease. When adjusted for the history of previous CV disease, diabetes, isolated systolic hypertension, the Framingham risk score, ECG-LVH and randomized study treatment, Cox regression models showed that incident LBBB predicted higher risk of the composite endpoint CV death, myocardial infarction and stroke [hazard ratio (HR) 1.9, 95% confidence intervals (CIs) 1.3–2.9, P < 0.001], CV death (HR 3.0, 95% CIs 1.84–5.0, P < 0.001), heart failure (HR 3.6, 95% CIs 1.9–6.6, P < 0.001) and all-cause mortality (HR 3.0, 95% CIs 2.0–4.3, P < 0.001). Conclusions: These data suggest that among hypertensive patients with ECG-LVH receiving aggressive antihypertensive therapy, incident LBBB independently predicts increased risk of subsequent CV events including congestive heart failure and CV and all-cause mortality (ClinicalTrials.gov identifier: NCT00338260).

[1]  P. Tabong,et al.  Acceptability of Breast Milk Donor Banking: A qualitative study among Health Workers in Greater Accra Regional Hospital, Ghana , 2023, medRxiv.

[2]  P. Okin,et al.  Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study , 2009, Journal of hypertension.

[3]  Y. Takeyama,et al.  Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats , 2009, Hypertension Research.

[4]  M. Nieminen,et al.  Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study , 2008, Journal of hypertension.

[5]  T. A. Aksnes,et al.  Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). , 2008, The American journal of cardiology.

[6]  J. Edelman,et al.  Population impact of losartan use on stroke in the European Union (EU): Projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study , 2004, Journal of Human Hypertension.

[7]  Lauri Toivonen,et al.  QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study , 2004, Hypertension.

[8]  M. Nieminen,et al.  Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study , 2004, Journal of Human Hypertension.

[9]  M. Nieminen,et al.  Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. , 2002, JAMA.

[10]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[11]  Luigi Tavazzi,et al.  Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. , 2002, American heart journal.

[12]  K. Ozdemir,et al.  Effect of the isolated left bundle branch block on systolic and diastolic functions of left ventricle. , 2001, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  M. Nieminen,et al.  Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. , 2001, Journal of hypertension.

[14]  P. Okin,et al.  Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients: The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study , 2000, Hypertension.

[15]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[16]  M. Dellborg,et al.  Bundle-branch block in a general male population: the study of men born 1913. , 1998, Circulation.

[17]  M. Nieminen,et al.  Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. , 1998, Hypertension.

[18]  L. Lind,et al.  Left ventricular geometry and function are related to electrocardiographic characteristics and diagnoses. , 1998, Clinical physiology.

[19]  M. Nieminen,et al.  The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. , 1997, American journal of hypertension.

[20]  W. Shen,et al.  Clinical significance of complete left bundle branch block in dilated cardiomyopathy. , 1995, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[21]  C. Grines,et al.  Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. , 1989, Circulation.

[22]  R. Hamby,et al.  Left bundle branch block: a predictor of poor left ventricular function in coronary artery disease. , 1983, American Heart Journal.

[23]  W. Kannel,et al.  Newly acquired right bundle-branch block: The Framingham Study. , 1979, Annals of internal medicine.

[24]  M. Campbell,et al.  The outlook with bundle-branch block. , 1969, British heart journal.

[25]  R. Mulcahy,et al.  Aetiology of bundle-branch block. , 1968, British heart journal.

[26]  S. Smith,et al.  THE PROGNOSIS OF COMPLETE LEFT BUNDLE BRANCH BLOCK. , 1965, American heart journal.

[27]  G. Bauer.  DEVELOPMENT OF BUNDLE BRANCH BLOCK. , 1964, The American journal of cardiology.

[28]  G. Bauer.  BUNDLE BRANCH BLOCK: SOME USUAL AND SOME UNUSUAL FEATURES. , 1964, Australasian annals of medicine.

[29]  L. E. Lamb,et al.  Electrocardiographic findings in 67,375 asymptomatic subjects. V. Left bundle branch block. , 1960, The American journal of cardiology.

[30]  P. White,et al.  Original communicationPrognosis in bundle branch block: II. Factors influencing the survival period in left bundle branch block , 1951 .

[31]  H. Rasmussen,et al.  PATHOGENESIS OF LEFT BUNDLE BRANCH BLOCK , 1948, British heart journal.

[32]  A. Graybiel,et al.  BUNDLE BRANCH BLOCK; AN ANALYSIS OF 395 CASES , 1933 .

[33]  L. E. Lamb,et al.  LEFT BUNDLE BRANCH BLOCK IN FLYING PERSONNEL. A REPORT OF 56 CASES. , 1964, Aerospace medicine.

[34]  P. D. White,et al.  Prognosis in bundle branch block. II. Factors influencing the survival period in left bundle branch block. , 1951, American heart journal.